Clinical Trials Update:&nbsp;Sept. 13, 2004
4422
(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:
642713
roundup Plus: IBM, Boeing team up for defense work...TI touts combo chip with VoIP, Wi-Fi...ContextWeb nabs $3 million.
540596
TUESDAY, Dec. 18 (HealthDay News) -- A new kind of drug designed to lower levels of "bad" low-density lipoprotein (LDL) cholesterol and reduce heart disease risk has proved safe and effective in a phase II clinical trial, researchers report.
454422
roundup Plus: IBM launches business research group...Verbatim to make discs with HP labeling feature...SWsoft teams with Acronis to boost virtual servers...Dell, Topspin tout InfiniBand clusters.
592462
roundup Plus: PC shipments up, but revenue less so, study says...BEA mobilizes corporate data...Web services outfits merge...Microsoft sets holiday Xbox bundle...PalmSource settles Digeo patent suit.
563594
The Kootenai Medical Center's North Idaho Cancer Center will begin offering some patients the option of taking part in trials of experimental cancer drugs, starting in January.
414602
Stock falls on news treatment failed a mid-stage trial, company will cease developing drug. NEW YORK  - AtheroGenics Inc.
445999
The Food and Drug Administration (FDA) learned yesterday from AstraZeneca that a large clinical trial comparing Iressa (gefitinib) with placebo in patients with non-small cell lung cancer who had failed other courses of cancer therapy showed no survival
320923
ASK YOUR DOCTOR ABOUT VIOXX . . . but not for the reasons Merck &amp; Co. recommends. Last week a Food and Drug Administration (FDA) study found a link with heart attacks, and several large health insurers said
383170
Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of HGS-ETR1 (agonistic human monoclonal antibody to TRAIL Receptor 1) in patients with advanced ...
5466
MONDAY, Sept. 10 (HealthDay News) -- Little more than one in eight phase II cancer clinical trials with encouraging results go forward to the larger, phase III stage that&#39;s needed to bring a new therapy to patients, a new study finds.
583563
a widely prescribed arthritis treatment - more than doubled patients&#39; risk of heart problems in a clinical study. The announcement, 11 weeks after Merck &amp; Co.
730807
WASHINGTON - The Food and Drug Administration (news - web sites) will examine clinical trial data for thousands of depressed adults to see if they, like children, suffered increased suicidal thoughts and behaviors while taking antidepressants.
548270
The findings of the 'American-Australian-African trial with DronedarONe In atrial fibrillation or flutter patients for the maintenance of Sinus rhythm' (ADONIS) trial, announced at the annual meeting of the ...
42202
roundup Plus: PalmSource settles Digeo patent suit...Maxtor loses its CFO--again...Profits, revenue climb at Rambus.
603771
roundup Plus: Shopping.com holders cut IPO shares...Transmeta starts new chip, warns on earnings...Keynote to buy researcher Vividence.
367540
WEDNESDAY, Dec. 8 (HealthDayNews) -- Two separate studies offer some good news about two drugs for the treatment of Parkinson's disease.